Pasithea Therapeutics Income Statement (2021-2024) | KTTA

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024
Revenue & cost
Revenue (Quarter) 0.01M0.01M0.22M0.24M-0.06M0.35M
Gross Profit (Quarter) 721.00-0.00M0.13M0.24M
Operating items
Research & Development (Quarter) 1.39M1.10M2.03M1.62M3.35M1.75M2.36M1.58M1.51M
Selling, General & Administrative (Quarter) 0.55M0.73M1.27M1.95M2.41M2.61M2.58M2.66M2.12M1.80M2.16M1.80M2.29M1.59M1.42M1.75M
Restructuring Costs (Quarter) 0.33M
Other Operating Expenses (Quarter) -3.09M
Operating Expenses (Quarter) 0.55M0.73M1.27M1.95M2.73M2.61M2.58M4.04M3.21M3.83M3.79M5.15M4.04M3.95M3.00M3.26M
Operating Income (Quarter) -0.55M-0.73M-1.27M-1.96M-2.40M-2.61M-3.86M-4.04M-3.21M-3.83M-3.79M-5.15M-4.04M-3.95M-3.00M-3.26M
EBIT (Quarter) -0.55M-0.73M-1.27M-1.96M-2.40M-2.61M-3.86M-4.04M-3.21M-3.83M-3.79M-5.15M-4.04M-3.95M-3.00M-3.26M
Non-operating items
Interest & Investment Income (Quarter) -0.34M0.13M0.17M0.15M0.11M0.08M0.08M
Other Non Operating Income (Quarter) 0.04M-0.03M-0.01M0.12M0.15M0.11M
Non Operating Income (Quarter) -0.25M2.59M0.83M0.42M-0.34M-0.06M-0.01M0.12M0.18M0.12M0.18M0.08M0.00M0.08M
Net income details
EBT (Quarter) -0.55M-0.73M-1.53M0.63M-1.57M-2.19M-4.19M-4.05M-3.27M-3.60M-3.61M-5.03M-3.86M-3.87M-3.00M-3.18M
Profit After Tax (Quarter) -0.55M-0.73M-1.53M0.63M-1.57M-2.66M-4.59M-5.12M-3.54M-3.76M-3.61M-5.03M-3.86M-3.87M-3.00M-3.18M
Income from Continuing Operations (Quarter) -0.55M-0.73M-1.53M0.63M-1.57M-2.19M-4.19M-4.05M-3.27M-3.60M-3.61M-5.03M-3.86M-3.87M-3.00M-3.18M
Consolidated Net Income (Quarter) -0.55M-0.73M-1.53M0.63M-0.33M-0.47M-0.40M-1.06M-0.27M-0.17M-0.02M-3.86M-3.87M-3.00M-3.18M
Income towards Parent Company (Quarter) -0.55M-0.73M-1.53M0.63M-0.33M-0.47M-0.40M-1.06M-0.27M-0.17M-0.02M-3.86M-3.87M-3.00M-3.18M
Net Income towards Common Stockholders (Quarter) -0.55M-0.73M-1.53M0.63M-0.33M-0.47M-0.40M-1.06M-0.27M-0.17M-0.02M-3.86M-3.87M-3.00M-3.18M
Additional items
EPS (Basic) (Quarter) -0.07-0.09-0.170.12-0.01-0.02-0.16-8.98-2.60-2.75-2.87-4.51-3.70-3.71-2.87-2.41
EPS (Weighted Average and Diluted) (Quarter) -0.09-0.180.06-0.01-0.09-0.16-8.98-2.60-2.75-2.87-4.51-3.70-3.71-2.87-2.41
Shares Outstanding (Weighted Average) (Quarter) 7.95M8.26M8.96M0.28M3.68M23.19M24.42M1.26M1.30M1.31M1.29M0.05M1.04M1.04M5.13
Shares Outstanding (Diluted Average) (Quarter) 8.26M8.44M10.40M23.01M23.44M24.42M1.26M1.30M1.31M1.29M1.23M1.04M1.04M1.04M
EBITDA (Quarter) -0.55M-0.73M-1.53M0.62M-1.58M-2.71M-4.67M-4.97M-3.54M-3.76M-3.62M-5.05M-3.86M-3.87M-3.03M-3.15M
Interest Expenses (Quarter) 0.01M-0.12M
Shares Outstanding (Quarter) 8.10M8.26M13.21M1.15M23.01M26.55M26.55M1.30M1.31M1.31M1.04M1.04M1.04M1.04M1.04M